Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily (RAET)

This study has been completed.
Information provided by:
Hospitales Universitarios Virgen del Rocío Identifier:
First received: May 4, 2010
Last updated: February 7, 2011
Last verified: February 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):